Jim Simons Accelerate Diagnostics, Inc Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$6.81 - $9.23 $542,076 - $734,708
-79,600 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$7.99 - $15.0 $845,981 - $1.59 Million
-105,880 Reduced 57.08%
79,600 $662,000
Q4 2020

Feb 10, 2021
BUY
$7.04 - $11.7 $765,107 - $1.27 Million
108,680 Added 141.51%
185,480 $1.41 Million
Q3 2020

Nov 13, 2020
BUY
$9.98 - $18.04 $766,464 - $1.39 Million
76,800 New
76,800 $819,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email